Years of practice, median (IQR) |
8.7 (4.2-19.4) |
8.8 (4.4-16.7) |
8.7 (4.1- 21.0) |
0.41 |
Hospital typea |
|
|
|
|
University-based |
295 (64.8) |
128 (66.3) |
167 (63.7) |
|
Community-based |
140 (30.8) |
50 (25.9) |
90 (34.4) |
0.003 |
Government |
20 (4.4) |
15(7.7) |
5(1.5) |
|
|
Maximum dose of loop diuretic in milligrams equivalent to furosemide dosing before determining diuretic resistance, mgs/dayb |
|
|
<100 |
10 (4.8) |
8 (4.4) |
2(8) |
|
100-250 |
131 (63.0) |
114(62.3) |
17 (68) |
|
251-500 |
53 (25.5) |
50 (27.3) |
3 (12) |
0.30 |
501-750 |
4(1.9) |
4(2.2) |
0 |
|
<751-1000 |
9 (4.3) |
6 (3.3) |
3 (12) |
|
>1000 |
1 (0.5) |
1 (0.55) |
0 |
|
|
Criteria for initiating fluid removalb,c |
|
|
|
|
Cumulative fluid balance (i.e., >1000 mL) |
14 (7.4) |
13 (7.8) |
1 (4.3) |
|
Fluid overload>10% of body weight |
10 (5.3) |
9 (5.4) |
1 (4.3) |
|
Ongoing need for fluid administration in the presence of oliguria |
19 (10.0) |
18 (10.8) |
1 (4.3) |
0.72 |
Persistent oliguria or anuria (i.e., urine output <0.5ml/kg/h for >12 hours) |
55 (28.9) |
49 (29.4) |
6 (26.1) |
|
Pulmonary edema with or without hypoxemia |
28 (14.7) |
25 (15.0) |
3 (13.0) |
|
Severe hypoxemia (i.e., PaO2/FiO2 ratio < 150) |
64 (33.7) |
53 (31.7) |
11 (47.8) |
|
|
Criteria used for prescribing UFNETb,c |
|
|
|
|
24-hour fluid balance |
21 (10.6) |
20 (11.5) |
1 (4.2) |
|
Cumulative fluid balance since ICU admission |
24 (12.1) |
23 (13.2) |
1 (4.2) |
|
Hemodynamic status (i.e., HR, BP, CVP, PPV, dose of vasopressors) Radiographic features suggestive of fluid overload |
141 (71.2) 6 (3.0) |
121 (69.5) 5(2.9) |
20 (83.3) 1 (4.2) |
0.61 |
Volume of anticipated fluid administration in the next 24 hours |
1 (0.5) |
1 (0.6) |
0 |
|
Weight gain since ICU admission |
5(2.5) |
4(2.3) |
1 (4.2) |
|
|
Intermittent hemodialysis, median (IQR) |
|
|
|
|
Percent use last month |
10.0 (2.2-30.0) |
10.0 (5.0-30.0) |
10.0 (2.0-30.0) |
0.29 |
Typical prescription, liters per session |
2.0 (2.0-3.0) |
2.0 (2.0-3.0) |
2.0 (1.6-2.4) |
0.07 |
|
Slow forms of IHD, median (IQR) |
|
|
|
|
Percent use last month |
1.0 (1.0-15.0) |
2.0(0-23.0) |
1.0(0-10.5) |
0.08 |
Typical prescription, liters per session |
2.0 (1Ό-2.5) |
2.0 (1.0-2.5) |
2.0 (1.2-2.4) |
0.17 |
|
Percent of assessment of prescribed-to- delivered dose, median (IQR) |
90.0(20.0-100.0) |
90.0 (50.0-100.0) |
72.5 (2.7-100.0) |
0.02 |
|
CKRT, median (IQR) |
|
|
|
|
Percent use last month |
60.0 (20.0-90.0) |
80.0(50.0-90.0) |
50.0(10.0-80.0) |
<0.001 |
Initial UFNET rate for hemodynamically stable patient, mL per hour |
100.0 (79.0-200.0) |
100.0 (100.0-197.0) |
100.0(52.0-200.0) |
0.96 |
Maximal UFNET rate for hemodynamically stable patient, ml per hour |
285.0(200.0-341.0) |
298.0 (200.0-351.0) |
253.5 (200.0-310.5) |
0.22 |
UFNETrate for hemodynamically unstable patient, ml per hour |
51.0(25.0-100.0) |
52.0 (49.0-100.0) |
51.0 (10.0-100.0) |
0.91 |
|
Method used to achieve UFNET d |
|
|
|
|
By varying ultrafiltration rate only |
205 (61.9) |
75 (54.3) |
130(67.4) |
|
By varying replacement fluid rate only |
13 (3.9) |
8 (5.8) |
5(2.6) |
0.04 |
By varying both ultrafiltration and replacement fluid rate |
113 (34.1) |
55(39.9) |
58 (30.1) |
|
|
How frequently did you check net fluid balancee |
|
|
|
|
1 hour |
211 (58.2) |
43 (28.7) |
168 (79.2) |
|
2 hours |
19 (5.2) |
10(6.7) |
9 (4.2) |
|
4 hours |
34 (9.4) |
24 (16.0) |
10 (4.7) |
|
6 hours |
13 (3.6) |
11 (7.3) |
2 (0.9) |
<0.001 |
8 hours |
16 (4.4) |
9 (6.0) |
7(3.3) |
|
12 hours |
34 (9.4) |
24 (16.0) |
10 (4.7) |
|
24 hours |
35 (9.7) |
29 (19.3) |
6(2.8) |
|